3 months ago
Ossia is scaling its commercialization to meet massive customer demand and appointing new senior leadership to drive company focus and delivery.
BELLEVUE, Wash.–(BUSINESS WIRE)–#Cota–Ossia Inc. (“Ossia”), the company that created Cota® Real Wireless Power™, today announced that it has retained Citigroup Global Markets Inc. (“Citi”) to serve as its financial advisor to Ossia. Citi will assist Ossia in the evaluation of potential strategic initiatives intended to drive the Company’s long-term growth and financial performance. In tandem with this financial partnership, Ossia has appointed Doug Stovall as Chief Executive Officer, Marty Feuerstein as Chief Operating Officer and Ossia’s Founder and Chief Technical Officer, Hatem Zeine will now also serve as the Company’s President.
LONDON, Jan. 7, 2021 /PRNewswire/ SVF Investment Corp. (the "Company") announced today the pricing of its initial public offering of 52,500,000 units at $10 per unit. The units will be listed
Max Stock Limited to Present at 2021 ICR Conference
Max Stock Limited to Present at 2021 ICR Conference Max Stock Limited (TASE: MAXO) (the Company) a leading general discount retailer of everyday essential items in Israel, today announced that the Company will participate in the 2021 ICR Conference. Management is scheduled to present on Tuesday, January 12, 2021 at 11:30 a.m. Eastern Standard Time. A live webcast of the presentation will be available at https://ir.maxstock.co.il
About Max Stock Max Stock is a leading general discount retailer of everyday essential items in Israel. We offer a broad selection of merchandise across six major categories, operating 50 stores across the country. For more information, please visit https://ir.maxstock.co.il
WAYNE, N.J., Jan. 07, 2021 Konica Minolta Healthcare Americas Inc. and strategic partner AGIMED, a leading healthcare distributor in Argentina, jointly
IPO Alert: Gracell Biotechnologies (GRCL)
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Gracell Biotechnologies is scheduled to make its debut on the Nasdaq Global Select Market today (January 8), under the ticker symbol GRCL.
The Suzhou, China-based Gracell Biotechnologies is a global clinical-stage biopharmaceutical company developing CAR-T cell therapies for cancer through its proprietary technology platforms-FasTCAR and TruUCAR.
The company has offered to sell 11.0 million American depositary shares at a price of $19 per ADS. The underwriters have an option for a period of 30 days to purchase up to an additional 1.65 million ADSs. The aggregate gross proceeds are expected to be $209.0 million. The global offering is scheduled to close on January 12, 2021.